Daylight photodynamic therapy: patient willingness to undertake home treatment

L. J. McLellan (Lead / Corresponding author), P. O'Mahoney, S. Logan, S. Yule, C. Goodman, A. Lesar, L. Fullerton, S. Ibbotson, E. Eadie

Research output: Contribution to journalLetterpeer-review

6 Citations (Scopus)
107 Downloads (Pure)


In the UK, almost one in four individuals over 60 are affected by actinic keratoses (AK), and this is a cause of significant morbidity in an ageing population, with risk of progression to squamous cell carcinoma. Daylight photodynamic therapy (dPDT) is an effective and simple treatment for field change AK, with similar efficacy to conventional PDT. Commonly, skin surface preparation is performed in a Dermatology clinic prior to dPDT. However, a recent German study by Karrer and colleagues investigated dPDT as a patient‐applied home‐delivered treatment for face and scalp AK and reported that patients who undertook this self‐administered treatment had high levels of efficacy, tolerance and patient satisfaction.

Original languageEnglish
Pages (from-to)834-835
Number of pages2
JournalBritish Journal of Dermatology
Issue number4
Early online date28 Mar 2019
Publication statusPublished - 1 Oct 2019

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Daylight photodynamic therapy: patient willingness to undertake home treatment'. Together they form a unique fingerprint.

Cite this